Learning Objectives:

1. Review and understand the effects of the COVID-19 pandemic has upon the delivery of hematopoietic stem cell transplantation and CAR T-cell therapy.

2.  Determination of which patients are appropriate candidates for either hematopoietic stem cell transplantation and CAR T-cell therapy.

3.  Management of patients whose hematopoietic stem cell transplantation and CAR T-cell therapy has been delayed.

 

 

Session date: 
04/30/2020 - 4:30pm to 5:30pm CDT
Location: 
UCMC ZOOM
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr.Michael Bishop